Lisaftoclax+homoharringtonine+cytarabine+aclarubicin

DRUG2 trials

Sponsors

First Affiliated Hospital of Zhejiang University

Conditions

Acute Myeloid LeukemiaAcute Myeloid Leukemia (AML)Lisaftoclax

Phase 2

Comparing the Efficacy of LDA, LHAA, and LA Regimens in Young Adults With Intermediate- and High-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy

Enrolling by invitationNCT07651163

First Affiliated Hospital of Zhejiang UniversityAcute Myeloid Leukemia (AML), Lisaftoclax

Start: 2026-03-01End: 2029-12-01Target: 450Updated: 2026-06-16

Comparing the Efficacy of the LDA, LHAA, and DA Regimens in Young Adults With Low-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy

Enrolling by invitationNCT07651176

First Affiliated Hospital of Zhejiang UniversityAcute Myeloid Leukemia, Lisaftoclax

Start: 2026-03-01End: 2029-12-01Target: 267Updated: 2026-06-16